Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

NCT01181960 COMPLETED

The purpose of this study is to build a data repository that can be used to understand pharmaceutical utilization patterns among patients being treated in community behavioral health organizations (CBHOs) for schizophrenia or bipolar I disorder.

Details

Lead sponsor	Janssen Scientific Affairs, LLC
Status	COMPLETED
Enrolment	1066
Start date	2010-08
Completion	2013-11

Conditions

• Schizophrenia
• Bipolar Disorder

Interventions

• Risperidone long acting injectable - New Starts
• Risperidone long acting injectable - Continuous Users
• Paliperidone Palmitate -New and Continuous Users
• Other Antipsychotics - New Starts

Primary outcomes

• The number of psychiatric hospitalizations, non-psychiatric hospitalizations, emergency room visits, and CBHO visits. — Up to 12 months.

Countries

United States